Alexander Gorshtein

1.0k total citations
41 papers, 717 citations indexed

About

Alexander Gorshtein is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Alexander Gorshtein has authored 41 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Alexander Gorshtein's work include Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adrenal and Paraganglionic Tumors (7 papers). Alexander Gorshtein is often cited by papers focused on Pituitary Gland Disorders and Treatments (11 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adrenal and Paraganglionic Tumors (7 papers). Alexander Gorshtein collaborates with scholars based in Israel, Canada and Germany. Alexander Gorshtein's co-authors include Ilan Shimon, Amit Akirov, Dania Hirsch, Carlos Benbassat, Eyal Robenshtok, Simona Grozinsky‐Glasberg, D Guedj, Gloria Tsvetov, Abraham Weinberger and Mirit Amit-Vazina and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Molecular and Cellular Endocrinology.

In The Last Decade

Alexander Gorshtein

38 papers receiving 702 citations

Peers

Countries citing papers authored by Alexander Gorshtein

Since Specialization

Citations

This map shows the geographic impact of Alexander Gorshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Gorshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Gorshtein more than expected).

Fields of papers citing papers by Alexander Gorshtein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Gorshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Gorshtein. The network helps show where Alexander Gorshtein may publish in the future.

Co-authorship network of co-authors of Alexander Gorshtein

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Gorshtein. A scholar is included among the top collaborators of Alexander Gorshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Gorshtein. Alexander Gorshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subacute Thyroiditis Following COVID-19 and COVID-19 Vaccination 2024 ·Endocrine Practice ·(unknown), Eyal Robenshtok, Alon Peretz, (unknown), (unknown), Doron Netzer, Arnon D. Cohen, Walid Saliba, Ilan Shimon, Alexander Gorshtein	1
2	Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas 2023 ·Pituitary ·(unknown), ‪Adi Turjeman‬‏, Dania Hirsch, Eyal Robenshtok, Gloria Tsvetov, Alexander Gorshtein, (unknown), Ilana Shraga-Slutzky, Yossi Manisterski, Amit Akirov, Ilan Shimon	5
3	Natural history of nonfunctioning pituitary macroadenomas followed without intervention: A retrospective cohort study 2023 ·Clinical Endocrinology ·(unknown), Eyal Robenshtok, Hadar Duskin‐Bitan, Gloria Tsvetov, Alexander Gorshtein, Amit Akirov, Ilan Shimon	5
4	Graves’ Disease Following COVID-19 Vaccination: A Population-based, Matched Case-control Study 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Alexander Gorshtein, ‪Adi Turjeman‬‏, Hadar Duskin‐Bitan, Leonard Leibovici, Eyal Robenshtok	5
5	Features of patients and fracture risk in hypoparathyroidism; a single center study 2023 ·Journal of Endocrinological Investigation ·(unknown), Dania Hirsch, Alexander Gorshtein, Hiba Masri‐Iraqi, Tzippy Shochat, Eyal Robenshtok, Ilan Shimon, Gloria Tsvetov	2
6	Resistant prolactinomas: a case series of 26 patients 2022 ·Endocrine ·Tamar Eshkoli, Merav Fraenkel, (unknown), (unknown), (unknown), Gloria Tsvetov, Alexander Gorshtein, (unknown), Yona Greenman, Ilan Shimon	5
7	Long-term safety and efficacy of long-acting pasireotide in acromegaly 2021 ·Endocrine ·Amit Akirov, Alexander Gorshtein, Idit Dotan, (unknown), (unknown), (unknown), Ilan Shimon	21
8	Benefits of a nurse-led home injection service for acromegaly patients treated with somatuline autogel 2020 ·Endocrine ·Amit Akirov, Hiba Masri‐Iraqi, Alexander Gorshtein, Hadar Duskin‐Bitan, (unknown), Ilan Shimon	2
9	Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative? 2020 ·Maturitas ·Hadar Duskin‐Bitan, (unknown), (unknown), Alexander Gorshtein, Hiba Masri‐Iraqi, Eyal Robenshtok, Talia Diker‐Cohen, Joelle Singer, Ilan Shimon, Dania Hirsch, Gloria Tsvetov	5
10	Gender differences in the presentation, course and outcomes of primary hyperparathyroidism 2020 ·Maturitas ·(unknown), Gloria Tsvetov, (unknown), Alexander Gorshtein, (unknown), Dania Hirsch	2
11	Low serum albumin levels predict short‐ and long‐term mortality risk in patients hospitalised to general surgery wards 2019 ·Internal Medicine Journal ·Amit Akirov, Alexander Gorshtein, (unknown), Tali Steinmetz, Tzippy Shochat, Ilan Shimon	23
12	Glycemic variability and mortality in patients hospitalized in general surgery wards 2019 ·Surgery ·Amit Akirov, Tzippy Shochat, Idit Dotan, Talia Diker‐Cohen, Alexander Gorshtein, Ilan Shimon	25
13	Outcomes of hyperglycemia in patients with and without diabetes hospitalized for infectious diseases 2018 ·Diabetes/Metabolism Research and Reviews ·Amit Akirov, Talia Diker‐Cohen, Hiba Masri‐Iraqi, Hadar Duskin‐Bitan, Ilan Shimon, Alexander Gorshtein	9
14	Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study 2018 ·Endocrine ·Ilan Shimon, (unknown), Alexander Gorshtein, (unknown), (unknown), (unknown), (unknown), (unknown), Mark Niven, Carmela Shechner, Yona Greenman	57
15	Calcium levels on admission and before discharge are associated with mortality risk in hospitalized patients 2017 ·Endocrine ·Amit Akirov, Alexander Gorshtein, Ilana Shraga-Slutzky, Ilan Shimon	34
16	Long-term outcomes in older patients with hyperglycemia on admission for ischemic stroke 2017 ·European Journal of Internal Medicine ·Alexander Gorshtein, Ilan Shimon, Tzippy Shochat, (unknown), Amit Akirov	7
17	IGF1 induces cell proliferation in human pituitary tumors – Functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors 2014 ·Molecular and Cellular Endocrinology ·Hadara Rubinfeld, (unknown), (unknown), Alexander Gorshtein, Zvi R. Cohen, Moshe Hadani, Haim Werner, Ilan Shimon	9
18	Clinical Course and Outcome of Nonfunctioning Pituitary Adenomas in the Elderly Compared with Younger Age Groups 2013 ·Endocrine Practice ·Eyal Robenshtok, Carlos Benbassat, Dania Hirsch, (unknown), Zvi R. Cohen, (unknown), Alexander Gorshtein, Yoel Toledano, Ilan Shimon	43
19	Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro 2009 ·Endocrine Related Cancer ·Alexander Gorshtein, Hadara Rubinfeld, (unknown), Marily Theodoropoulou, (unknown), Günter K. Stalla, Zvi R. Cohen, Moshe Hadani, Ilan Shimon	65
20	The environment and antiphospholipid syndrome 2006 ·Lupus ·Yair Levy, (unknown), Alexander Gorshtein, Yehuda Shoenfeld	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact